COLLABORATIVE DATA SHARING AND CROSS-LICENSE AGREEMENT FOR IL-21 PROTEIN by and between ZymoGenetics, Inc. and Novo Nordisk A/S Effective Date: August 11, 2005Collaborative Data Sharing and Cross-License Agreement • November 3rd, 2005 • Zymogenetics Inc • Biological products, (no disgnostic substances) • Washington
Contract Type FiledNovember 3rd, 2005 Company Industry JurisdictionThis Collaborative Data Sharing Agreement for IL-21 Protein (“Agreement”) is effective as of August 11, 2005 (the “Effective Date”) and is entered into by and between ZymoGenetics, Inc., a Washington corporation having a principal place of business at 1201 Eastlake Avenue East, Seattle, Washington 98102 (“ZGEN”), and Novo Nordisk A/S, a Danish corporation having a principal place of business at Novo Alle, DK-2880, Bagsvaerd, Denmark (“NN”).